[Countermeasure for adverse effects of therapeutic agents for systemic lupus erythematosus].
Torikai
K
K
D003920:Diabetes Mellitus / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007239:Infections / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D010024:Osteoporosis / Q000209:etiology; D011239:Prednisolone / Q000009:adverse effects*; D011788:Quality of Life
D007166:Immunosuppressive Agents; D011239:Prednisolone